NICM
HIMS icon

Neo Ivy Capital Management’s Hims & Hers Health HIMS Stock Holding History

Neo Ivy Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Sell
98,582
-92,333
-48% -$2.18M 0.54% 72
2025
Q4 		$6.2M Buy
190,915
+126,697
+197% +$5.43M 0.98% 17
2025
Q3 		$3.64M Buy
64,218
+7,273
+13% +$373K 0.89% 15
2025
Q2 		$2.84M Buy
56,945
+37,107
+187% +$1.68M 0.91% 17
2025
Q1 		$586K Sell
19,838
-146,896
-88% -$5.46M 0.19% 151
2024
Q4 		$4.03M Buy
166,734
+98,798
+145% +$2.45M 0.81% 21
2024
Q3 		$1.25M Buy
+67,936
New +$1.22M 0.41% 103

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Neo Ivy Capital Management's HIMS Position: Q1 2026 in Review

Neo Ivy Capital Management reduced its Hims & Hers Health (HIMS) stake by 48% in Q1 2026, selling an estimated $2.18M and leaving 98,582 shares worth $2.05M. The position accounts for 0.54% of the portfolio, ranked #72.

Neo Ivy Capital Management first reported a position in HIMS in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.2M in Q4 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Neo Ivy Capital Management held 98,582 shares of Hims & Hers Health worth $2.05M as of Q1 2026.
  • Neo Ivy Capital Management sold 92,333 Hims & Hers Health shares in Q1 2026, an estimated $2.18M.
  • Hims & Hers Health made up 0.54% of Neo Ivy Capital Management's portfolio in Q1 2026, its #72 holding.
  • Neo Ivy Capital Management first reported a position in Hims & Hers Health in Q3 2024 and has held it in 7 quarters since.
  • Neo Ivy Capital Management's Hims & Hers Health position peaked at $6.2M in Q4 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.